-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Zenas BioPharma, Inc. quarterly/annual Revenues history and growth rate from Q3 2023 to Q2 2025.
- Zenas BioPharma, Inc. Revenues for the quarter ending June 30, 2025 was $0.000.
- Zenas BioPharma, Inc. annual Revenues for 2024 was $5M, a 90% decline from 2023.